Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | -11.9x - -13.1x | -12.5x |
| Historical Pb Multiple | 1.4x - 22.0x | 7.2x |
| Fair Value | ¥2.10 - ¥2.33 | ¥2.21 |
| Upside | -52.9% - -48.0% | -50.4% |
| Benchmarks | - | Full Ticker |
| Jiangxi Fushine Pharmaceutical Co., Ltd. | 30,049,700.0% | SZSE:300497 |
| Ji Yao Holding Group Co., Ltd. | 30,010,800.0% | SZSE:300108 |
| Hunan Hansen Pharmaceutical Co., Ltd. | 241,200.0% | SZSE:002412 |
| Shandong Sinobioway Biomedicine Co., Ltd. | 258,100.0% | SZSE:002581 |
| Fujian Cosunter Pharmaceutical Co., Ltd. | 30,043,600.0% | SZSE:300436 |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 90,800.0% | SZSE:000908 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 300497 | 300108 | 2412 | 2581 | 300436 | 908 | |||
| SZSE:300497 | SZSE:300108 | SZSE:002412 | SZSE:002581 | SZSE:300436 | SZSE:000908 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | 6.8% | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | 24.5% | NM- | NM- | NM- | ||
| Latest Twelve Months | 32.6% | -289.6% | 53.5% | -603.3% | 11.3% | -122.4% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 2.5% | -112.3% | 17.8% | -11.4% | -27.5% | -66.7% | ||
| Prior Fiscal Year | -8.6% | -56.4% | 18.3% | -4.1% | -33.0% | -14.6% | ||
| Latest Fiscal Year | -12.5% | -100.9% | 21.5% | -77.4% | -82.5% | -32.8% | ||
| Latest Twelve Months | -13.9% | -120.3% | 23.4% | -85.6% | -47.6% | -71.9% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 3.9% | -659.5% | 9.2% | -2.1% | -14.1% | -109.6% | ||
| Prior Fiscal Year | -5.1% | -716.4% | 9.2% | -0.6% | -12.9% | -52.0% | ||
| Latest Twelve Months | -7.3% | NM | 11.4% | -15.4% | -40.1% | -442.2% | ||
| Next Fiscal Year | #NUM! | #NUM! | 9.1% | #NUM! | #NUM! | #NUM! | ||
| Two Fiscal Years Forward | -8.7% | 76.6% | 8.5% | -21.6% | -120.3% | 112.8% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 3.5x | 1.7x | 3.2x | 15.3x | 11.0x | 9.9x | ||
| Price / LTM EPS | -25.1x | -1.4x | 13.6x | -17.9x | -23.2x | -13.8x | ||
| Price / Book | 1.9x | -1.2x | 1.5x | 3.0x | 11.6x | -25.3x | ||
| Price / Fwd Book | 1.9x | -2.2x | 1.5x | 3.0x | 11.0x | -54.6x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | -1.2x | 1.9x | 11.6x | |||||
| Historical P/B Ratio | 1.4x | 7.2x | 22.0x | |||||
| Selected P/B Multiple | -11.9x | -12.5x | -13.1x | |||||
| (x) Book Value | (156) | (156) | (156) | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 300497 | 300108 | 2412 | 2581 | 300436 | 908 | |
| Value of Common Equity | 4,708 | 606 | 3,170 | 6,294 | 5,485 | 3,933 | |
| (/) Shares Outstanding | 538.6 | 666.0 | 503.2 | 659.7 | 159.3 | 879.8 | |
| Implied Stock Price | 8.74 | 0.91 | 6.30 | 9.54 | 34.44 | 4.47 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 8.74 | 0.91 | 6.30 | 9.54 | 34.44 | 4.47 | |
| Trading Currency | CNY | CNY | CNY | CNY | CNY | CNY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |